Company: MIRA
Filing Date: 2025-07-29
Form Type: PRER14A
Source: 0001641172-25-021434
Chunk: 8

Company: MIRA PHARMACEUTICALS, INC.
Filing Date: 2025-07-29
Form: PRER14A
Chunk 8
---
 (the “Board”) to serve until the next annual meeting of                       
 the stockholders of the Company or until their successors have been duly elected or appointed and qualified (“Director Appointment          
 Proposal”, or “Proposal No. 2”);                                                                                                            
 To                                                                                                                                          
 ratify the appointment of Salberg & Company, P.A. as the Company’s independent registered public accounting firm for the                    
 fiscal year ending December 31, 2025 (“Auditor Appointment Proposal”, or “Proposal No. 3”);                                                 
 To                                                                                                                                          
 approve certain amendments to the 2022 Omnibus Incentive Plan (the “Plan”) to increase the number of shares available                       
 under the Plan (“Plan Amendment Proposal”, or “Proposal No. 4”);                                                                            |
|:---|:--------------------------------------------------------------------------------------------------------------------------------------------|
| 5  | To                                                                                                                                          
 approve the adjournment of the Annual Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies     
 if, based upon the tabulated vote at the time of the Annual Meeting, there are not sufficient votes to approve the Director Appointment     
 Proposal, Auditor Appointment Proposal, and/or Plan Amendment Proposal (the “Adjournment Proposal”, or “Proposal                            
 No. 5”, and together with the Merger Proposal, Director Appointment Proposal, Auditor Appointment Proposal, and Plan Amendment              
 Proposal the “Proposals”); and                                                                                                              |

To conduct any other business as may properly come before the meeting or any adjournment thereof.

Q: What are the Board’s voting recommendations?

A:The Board recommends that you vote “FOR” each of the Proposals.

Q: How can I find out the results of the voting at the MIRA Annual Meeting?

A:Final voting results will be published in a current report on Form 8-K that we expect to file within four business days after the Annual Meeting. If final voting results are not available to us in time to file a Form 8-K within four business days after the MIRA Annual Meeting, we intend to file a Form 8-K to publish preliminary results and, within four business days after the final results are known to us, file an additional Form 8-K to publish the final results.

Q: What is the difference between holding shares as a record holder and as a beneficial owner?

A:If your shares are registered in your name with the Company’s transfer agent, American Stock Transfer (also known as Equiniti), you are the “record holder” of those shares. If you are a record